← back to search

Phyu P. Aung

The University of Texas MD Anderson Cancer Center · US
Area of research
Oncology · Dermatology
Research interest
Research interests include Cutaneous Melanoma Detection and Management, Cutaneous lymphoproliferative disorders research, Polyomavirus and related diseases, and Cancer and Skin Lesions.
h-index
39
citations
5,990
works
324
NIH funding
primary concept
email

Recent publications

A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland
Human Pathology 2024cited by 11position: middledoi
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease
JAMA Oncology 2022cited by 135position: middledoi
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Blood 2022cited by 56position: middledoi
An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases
Archives of Pathology & Laboratory Medicine 2022cited by 22position: middledoi
Severe de novo pustular psoriasiform immune‐related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma
Journal of Cutaneous Pathology 2021cited by 11position: middledoi
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma
Journal of Investigative Dermatology 2020cited by 22position: middledoi
Prognostic significance of acral lentiginous histologic type in T1 melanoma
Modern Pathology 2020cited by 18position: lastdoi
The “-OMICS” facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers
Seminars in Cancer Biology 2019cited by 32position: middledoi
PTEN functions as a melanoma tumor suppressor by promoting host immune response
Oncogene 2013cited by 113position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jonathan L. Curry · The University of Texas MD Anderson Cancer Center3 papers (2020–2021)Carlos A. Torres‐Cabala · Roswell Park Comprehensive Cancer Center3 papers (2020–2021)Priyadharsini Nagarajan · The Ohio State University Wexner Medical Center3 papers (2020–2021)Michael T. Tetzlaff · The University of Texas MD Anderson Cancer Center2 papers (2020–2020)Víctor G. Prieto · Disco (Germany)2 papers (2020–2020)Christiane Querfeld · City Of Hope National Medical Center1 papers (2022–2022)Alejandro A. Gru · Columbia University Irving Medical Center1 papers (2022–2022)Ignacio I. Wistuba · Disco (Germany)1 papers (2020–2020)Robert S. Ohgami · University of Utah1 papers (2022–2022)Sheeja T. Pullarkat · University of California, Los Angeles1 papers (2022–2022)Dirk Schadendorf · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori1 papers (2020–2020)Jennifer A. Wargo · The University of Texas MD Anderson Cancer Center1 papers (2020–2020)Constance T. Albarracin · The University of Texas MD Anderson Cancer Center1 papers (2024–2024) · 1 papers (2021–2021)Xiao Huang · University of Alabama at Birmingham1 papers (2024–2024)Narendra Wajapeyee · University of Alabama at Birmingham1 papers (2013–2013)Ayşegül A. Şahin · The University of Texas Health Science Center at Houston1 papers (2024–2024)Merrick I. Ross · The University of Texas MD Anderson Cancer Center1 papers (2020–2020)Maya Farah · Boston Medical Center1 papers (2020–2020)Mohammad Hussaini · Moffitt Cancer Center1 papers (2022–2022)